Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar 17:3:67-79.

GRIM-19: A Double-edged Sword that Regulates Anti-Tumor and Innate Immune Responses

Affiliations

GRIM-19: A Double-edged Sword that Regulates Anti-Tumor and Innate Immune Responses

Shreeram C Nallar et al. Transl Oncogenomics. .

Abstract

Gene associated with retinoid-interferon-β-induced mortality (GRIM)-19, was originally identified as a critical regulatory protein necessary for Interferon-β-Retinoic acid-induced cell death. Overexpression of GRIM-19 activates cell death and its suppression or inactivation promotes cell growth. GRIM-19 targets multiple proteins/pathways for exerting growth control and cell death. However, GRIM-19 is also required for normal cellular processes. In addition, viruses 'hijack' GRIM-19 for their survival. Intracellular bacterial infections and bacterial products have been reported to induce the expression of GRIM-19. In this review, we will discuss the current status of GRIM-19 in growth control and innate immune response.

Keywords: apoptosis; cytokines; transcriptional inhibition and immune response; tumor suppression.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Viral Inhibitors of GRIM-19. Viruses effectively block GRIM-19’s action either by preventing its release from mitochondria and/or its action by sequestering with viral gene products. Lines in Red indicate blockade of GRIM-19 action involving the indicated viral components. Lines in Green indicate transcriptional repression. Mechanism of transcriptional repression is not known.
Figure 2
Figure 2
Cellular roles of GRIM-19. GRIM-19 appears to have more functions than previously envisaged: 1) It targets growth-promoting proteins, STAT3 and Src, to achieve growth control; 2) It augments the activity of HtrA2 to cleave XIAP; 3) In conjunction with NOD2 it participates in innate immune responses. GRIM-19 can perform these functions only when it is present in more than one intra-cellular compartment. For example, nuclear and cytosolic GRIM-19 can effectively block STAT3 and Src, respectively. GRIM-19 overexpression effectively blocks cell motility by decreasing tubulin polymerization. Upon IFN/RA stimulation, the de-novo synthesized GRIM-19 participates in growth control in conjunction with other proteins. Requirement of GRIM-19 for complex-I assembly and stability vis-à-vis ATP generation, is one of its reported functions. Red colored-lines and arrows represent GRIM-19-dependent inhibitory and stimulatory pathways, respectively. Blue colored lines and arrows represent STAT3-dependent inhibitory and stimulatory pathways, respectively. Green arrows represent novel GRIM-19 inductive and functional pathways. P in green and pink colored circles indicate phosphorylations at Serine 727 and tyrosine 705 residues, respectively.
Figure 3
Figure 3
Function of GRIM-19 in steady-state. Coordinated synthesis cum assembly of mitochondrial complex-I has been well-characterized. In addition to the structural and functional proteins in complex-I, distantly-related proteins like GRIM-19 and AIF are required for proper complex-I formation. Homozygous deletion of grim19 resulted in embryonic lethality in mice which may be a result of decreased complex-I levels in the developing embryo. M-coded—mitochondrial DNA-encoded, N-coded—Nuclear DNA-encoded.

Similar articles

Cited by

References

    1. Agarwal S, Piesco NP, Johns LP, Riccelli AE. J. Dent. Res. 1995;74:1057–65. - PubMed
    1. Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T. Cell. 1994;77:63–71. - PubMed
    1. Alchanati I, Nallar SC, Sun P, Gao L, Hu J, Stein A, Yakirevich E, Konforty D, Alroy I, Zhao X, Reddy SP, Resnick MB, Kalvakolanu DV. Oncogene. 2006;25:7138–47. - PubMed
    1. Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, Sprigg NS, Corbin JE, Cornish AL, Darwiche R, Owczarek CM, Kay TW, Nicola NA, Hertzog PJ, Metcalf D, Hilton DJ. Cell. 1999;98:597–608. - PubMed
    1. Angell JE, Lindner DJ, Shapiro PS, Hofmann ER, Kalvakolanu DV. J. Biol. Chem. 2000;275:33416–26. - PubMed

LinkOut - more resources